Biomea Fusion (BMEA) Insider Trading & Ownership $1.54 -0.09 (-5.52%) Closing price 08/8/2025 04:00 PM EasternExtended Trading$1.54 0.00 (0.00%) As of 08/8/2025 07:49 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Biomea Fusion (NASDAQ:BMEA) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage18.42%Number OfInsiders Buying(Last 12 Months)1Amount OfInsider Buying(Last 12 Months)$100.60KNumber OfInsiders Selling(Last 12 Months)0 Get BMEA Insider Trade Alerts Want to know when executives and insiders are buying or selling Biomea Fusion stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address BMEA Insider Buying and Selling by Quarter Biomea Fusion Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails9/30/2024Michael J.M. HitchcockDirectorBuy10,000$10.06$100,600.00 (Data available from 1/1/2013 forward) BMEA Insider Trading Activity - Frequently Asked Questions Who is on Biomea Fusion's Insider Roster? The list of insiders at Biomea Fusion includes A2a Pharmaceuticals, Inc., Bihua Chen, and Michael J.M. Hitchcock. Learn more on insiders at BMEA. What percentage of Biomea Fusion stock is owned by insiders? 18.42% of Biomea Fusion stock is owned by insiders. Learn more on BMEA's insider holdings. Which Biomea Fusion insiders have been buying company stock? The following insider purchased BMEA shares in the last 24 months: Michael J.M. Hitchcock ($100,600.00). How much insider buying is happening at Biomea Fusion? Insiders have purchased a total of 10,000 BMEA shares in the last 24 months for a total of $100,600.00 bought. Biomea Fusion Key ExecutivesMr. Thomas Andrew Butler (Age 43)Co-Founder, Chairman & CEO Compensation: $950.41kMr. Ramses M. Erdtmann (Age 61)Co-Founder, President, COO & Director Mr. Franco Valle (Age 43)CFO & Principal Accounting Officer Compensation: $673.66kDr. Juan Pablo Frias M.D.Chief Medical OfficerMr. Heow Tan (Age 65)Chief Technology & Quality Officer Ms. Naomi CretcherChief People OfficerDr. Thorsten Kirschberg Ph.D. (Age 54)Executive Vice President of Chemistry Dr. Stephan Morris M.D.Chief Development OfficerMr. Ravi UpasaniExecutive Vice President of Intellectual PropertyCaroline Perez- DupontSenior Vice President of Contracts More Insider Trading Tools from MarketBeat Related Companies Monopar Therapeutics Insider Transactions Cardiff Oncology Insider Transactions Editas Medicine Insider Transactions DBV Technologies Insider Transactions Inozyme Pharma Insider Transactions Bright Minds Biosciences Insider Transactions Larimar Therapeutics Insider Transactions Entrada Therapeutics Insider Transactions Replimune Group Insider Transactions Aerovate Therapeutics Insider Transactions Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Strategy Insiders Buy In While Analysts Predict Big UpsideThe Bottom Is in For These 3 Small-Cap Stocks Insiders Are Buying3 Catalysts Driving Plug Power’s Turnaround CaseInsider Selling Hits Market Leaders—Should You Be Worried?Insiders Spent Millions on These 3 Stocks Over the Past 2 Months This page (NASDAQ:BMEA) was last updated on 8/10/2025 by MarketBeat.com Staff From Our PartnersGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | Sponsored"Death Spiral" Threatening Your SavingsThe "Death Spiral" Threatening Your Savings But this time, it's not just Dalio ringing the alarm bells…Goldco Precious Metals | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | SponsoredMarket Crash Warning: How to Protect Your Wealth Before August 12thChina tariffs hit August 12—and experts warn a market meltdown may follow. A free guide from American Alter...American Alternative | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredNational 'Stock Market Reset' Coming September 30 (New WH Order)Crash Coming Sept 30? Analysts Warn of New Crisis A new problem on the U.S. power grid is putting millions ...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Biomea Fusion, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Biomea Fusion With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
